Skip to main content
NIH funding notice RFA-HL-21-003

Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)

Closed on October 2, 2020.

Posted
June 2, 2020
Close date
October 2, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$532,188
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1

Most frequent study sections

  1. Special Emphasis Panel (ZHL1 CSR-E (M1))1
1 award under RFA-HL-21-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2021Injection of autologous volar fibroblasts to the stump site to allow pressure adaptation and enhanced prosthetic use in amputees1UG3AR079376-01Garza, Luis AndresJOHNS HOPKINS UNIVERSITY, MDFirst-year cost $532,188Study section ZHL1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.